Table 3.
Antimicrobial resistance of isolated Gram-negative bacteria in diabetic patients
| Antibiotics | Isolated bacteria |
|||||||
|---|---|---|---|---|---|---|---|---|
| Escherichia coli (n = 87) | Enterobacter spp. (n = 17) | Citrobacter spp. (n = 2) | Acinetobacter spp. (n = 2) | Klebsiella spp. (n = 2) | Proteus spp. (n = 1) | Pseudomonas aeruginosa (n = 1) | ||
| SXT | R (%) | 55.17 | 47.05 | 0 | 0 | 50 | 0 | – |
| NA | R (%) | 55.17 | 35.29 | 0 | – | 0 | 0 | – |
| NI | R (%) | 2.29 | 29.41 | 50 | – | 50 | – | – |
| NOR | R (%) | 35.63 | 23.52 | 0 | – | 0 | 0 | 0 |
| CIP | R (%) | 36.78 | 23.52 | 0 | 50 | 0 | 0 | 0 |
| AUG | R (%) | 87.35 | –a | – | – | 100 | 100 | – |
| ZOX | R (%) | 19.54 | 11.76 | 0 | – | 0 | 0 | – |
| GM | R (%) | 31.03 | 17.64 | 0 | 50 | 0 | 0 | 0 |
| CFM | R (%) | 31.03 | 41.17 | 0 | – | 50 | 0 | – |
| CAZ | R (%) | 26.46 | 23.52 | 0 | 0 | 50 | 0 | 0 |
| CRO | R (%) | 26.46 | 17.64 | 0 | 0 | 50 | 0 | – |
| CTX | R (%) | 37.93 | 0 | 0 | 0 | 0 | 0 | – |
Abbreviations: AUG, amoxicillin-clavulanic acid; CAZ, ceftazidime; CFM, cefixime; CIP, ciprofloxacin; CRO, ceftriaxone; CTX, cefotaxime; GM, gentamicin; NA, nalidixic acid; NI, nitrofurantoin; NOR, norfloxacin; SXT, trimethoprim-sulfamethoxazole; ZOX, ceftizoxime.
a
This antibiotic was not used for this bacterium.